Peer Review reports
From: BUB1 serves as a biomarker for poor prognosis in liver hepatocellular carcinoma
| Original Submission | ||
|---|---|---|
| 1 Dec 2024 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 23 Dec 2024 | Reviewed | Reviewer Report - Ester Badami |
| 31 Dec 2024 | Reviewed | Reviewer Report |
| 21 Jan 2025 | Author responded | Author comments - Lili Zhang |
| Resubmission - Version 3 | ||
| 21 Jan 2025 | Submitted | Manuscript version 3 |
| 23 Jan 2025 | Author responded | Author comments - Lili Zhang |
| Resubmission - Version 4 | ||
| 23 Jan 2025 | Submitted | Manuscript version 4 |
| 24 Jan 2025 | Author responded | Author comments - Lili Zhang |
| Resubmission - Version 5 | ||
| 24 Jan 2025 | Submitted | Manuscript version 5 |
| 30 Jan 2025 | Reviewed | Reviewer Report - Ester Badami |
| 8 Feb 2025 | Reviewed | Reviewer Report |
| 17 Feb 2025 | Author responded | Author comments - Lili Zhang |
| Resubmission - Version 6 | ||
| 17 Feb 2025 | Submitted | Manuscript version 6 |
| 20 Feb 2025 | Author responded | Author comments - Lili Zhang |
| Resubmission - Version 7 | ||
| 20 Feb 2025 | Submitted | Manuscript version 7 |
| 26 Feb 2025 | Reviewed | Reviewer Report |
| Resubmission - Version 8 | ||
| Submitted | Manuscript version 8 | |
| Publishing | ||
| 27 Feb 2025 | Editorially accepted | |
| 11 Mar 2025 | Article published | 10.1186/s12865-025-00698-4 |
You can find further information about peer review here.